Number of the records: 1
syndróm anticholinergický
SYS d064807 LBL 00000cz--a2200181n--4500 005 20250606221129.8 008 140101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $a BA006 $d BA006 $d BA006 065 $a C25.100.311 066 $a 01 $c 03 150 $a syndróm anticholinergický $x BL $x CF $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $2 slo 450 $w v $a syndróm anticholinergický centrálny $2 slo 450 $w v $a syndróm anticholinergický periférny $2 slo 550 $7 sllk_us_auth*d018680 $Y Cholinergic Antagonists $w b $a antagonisty cholínergické 550 $7 sllk_us_auth*d018680 $Y Cholinergic Antagonists $w p $a antagonisty cholínergické 665 $a 2014 $2 eng 665 $a Cholinergic Antagonists (1995-2013) $2 eng 680 9-
$i Adverse drug effects associated with CHOLINERGIC ANTAGONISTS. Clinical features include TACHYCARDIA; HYPERTHERMIA; MYDRIASIS, dry skin and dry mucous membranes, decreased bowel sounds and urinary retention in peripheral anticholinergic syndrome; and HALLUCINATIONS; PSYCHOSES; SEIZURES; and COMA in central anticholinergic syndrome. $2 eng 750 -2
$a Anticholinergic Syndrome $2 eng 980 $x M
Number of the records: 1